Recent
- Australia Becomes the First Country to Prescribe Psychedelics to Treat Depression and PTSD
- The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off
- Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer Patients
- ‘Right To Try Laws’ and Legal Access to Psilocybin Therapy with Dr. Jonathan Fields
- Compass Pathways Phase 2 Psilocybin Results far from Spectacular
- Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop
- Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS
- Psychedelic Stocks: ARK Invest and the Reverse Midas Touch
- Compass Pathways Sued for Stealing Trade Secrets
- Three Phase 3 Clinical Trials that Could Legalize Psychedelics
COMPASS Pathways
Public Company
[stockdio-historical-chart symbol="CMPS" stockExchange="" palette="financial-light"]